Martin Shkreli

US FTC Wants Court to Hold “Pharma Bro” in Contempt

The Federal Trade Commission (FTC) has asked a US federal judge to hold “pharma bro” Martin Shkreli in contempt for forming another drug company that it said violates a January 2022 court order that banned him from working in the pharmaceutical industry

Shkreli’s Fraud Trial Set for June 2017

Turing Lawyer Says He Warned Over Pill Hike

Shkreli Gives US Congress Cold Shoulder

Class Action Suit Filed Against KalaBios

Turing Chief Arrested for Securities Fraud

Valeant under Pressure From US Legislators

Turing Says it Will Cut Daraprim Price